Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
Benefits for type 2 diabetes of interrupting prolonged sitting.
Biomarkers that highlight toxic fats in the liver.
Imaging athletes’ hearts during exercise, not at rest.
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.
Find out more
